2026年11月4日星期三
M
विश्व व्यापक संदर्भ
वैश्विक ताज़ा ख़बरें
NTT to help Japanese companies update at-risk aging IT with AI— 日经 Nikkei Asia5 things to know about the US midterms and what they mean for Asia— 日经 Nikkei AsiaChina's cable-cutting threat reaches Taiwan and the Philippines— 日经 Nikkei AsiaVienna entrepreneur takes leaders on lux train to China to foster ties— 日经 Nikkei AsiaBangladesh garment factories become second schools for women— 日经 Nikkei AsiaThailand to raise tax on imported EVs to 35% as Chinese brands gain ground— 日经 Nikkei AsiaWhy PC makers are turning back to China— 日经 Nikkei AsiaIndonesia chief of staff sacked for allegedly wiretapping President Prabowo— 日经 Nikkei AsiaNTT to help Japanese companies update at-risk aging IT with AI— 日经 Nikkei Asia5 things to know about the US midterms and what they mean for Asia— 日经 Nikkei AsiaChina's cable-cutting threat reaches Taiwan and the Philippines— 日经 Nikkei AsiaVienna entrepreneur takes leaders on lux train to China to foster ties— 日经 Nikkei AsiaBangladesh garment factories become second schools for women— 日经 Nikkei AsiaThailand to raise tax on imported EVs to 35% as Chinese brands gain ground— 日经 Nikkei AsiaWhy PC makers are turning back to China— 日经 Nikkei AsiaIndonesia chief of staff sacked for allegedly wiretapping President Prabowo— 日经 Nikkei Asia

Author Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

स्रोत Nature 医学研究8 दिन पहले
सामग्री सारांश

यह साइट केवल शीर्षक और सारांश सूचकांक प्रदान करती है, पूरी सामग्री और कॉपीराइट मूल प्रकाशक के पास हैं, कृपया मूल लिंक पर क्लिक करके पढ़ें।

मूल पाठ पर जाएं
संबंधित चैनल
स्वास्थ्य
संबंधित क्षेत्र
वैश्विक दृष्टिकोण
मूल भाषा
English
प्रविष्टि संख्या
health-a90987bb

Comments 0 comments

No comments yet. Be the first.

Author Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial · विश्व व्यापक संदर्भ